The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 1989-1995

  Yuen, Kevin ^a,b,c,d,e,f   Ong, Ken ^a,b,c,d,e,f   Husbands, Sandra ^a,b,c,d,e,f   Chatelain, Pierre ^a,b,c,d,e,f   Fryklund, Linda ^a,b,c,d,e,f   Gluckman, Peter ^a,b,c,d,e,f   Ranke, Michael ^a,b,c,d,e,f   Cook, David ^a,b,c,d,e,f   Rosenfeld, Ron ^a,b,c,d,e,f   Wass, John ^a,b,c,d,e,f   Dunger, David ^a,b,c,d,e,f  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c PFIZER INC   (United States)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CELL FUNCTION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE SUBSTITUTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SEX DIFFERENCE; SHORT COURSE THERAPY;

EID: 18344362250     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.8460     Document Type: Article

References (49)

1. Effect of growth hormone on carbohydrate and lipid metabolism
2. Growth hormone and metabolism
3. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man
4. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans
5. Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans
6. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency
7. On the diabetogenic effect of growth hormone in man: Effects of growth hormone of glucagon and insulin secretion
8. Insulin-like and diabetogenic effects of growth hormone in healthy subjects, diabetics, and low insulin responders
9. Acute suppressive effect of human growth hormone on basal insulin secretion in man
10. Acute metabolic effects of human growth hormone
11. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a post receptor site
12. Growth hormone-induced insulin resistance: Role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4
13. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
14. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
15. Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: Effects of gender
16. An amplitude-specific divergence in the pulsatile mode of growth hormone secretion underlies the gender difference in mean growth hormone concentrations in men and premenopausal women
17. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
18. Correct homeostasis model assessment (HOMA) evaluation uses the computer program
19. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
20. The homeostasis model in the San Antonio heart study
21. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
22. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
23. Binding protein for the insulin-like growth factors: Structure, regulation and function
24. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults
25. Dose-response study of GH effects on circulating IGF-I and IGFBF-3 levels in healthy young men and women
26. Dose-response studies on the metabolic effects of a growth hormone pulse in humans
27. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender
28. Which adults develop side-effects of growth hormone replacement?
29. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults
30. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners
31. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency
32. Optimizing GH replacement therapy by dose titration in hypopituitary adults
33. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults
34. A low starting dose of genotropin in growth hormone-deficient adults
35. Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: Responses after acute and chronic human growth hormone administration
36. Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature
37. Risk of hypoglycaemia with alternate-day growth hormone injections
38. Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man
39. Kinetics of the somatomedin C/insulin-like growth factor 1 response to exogenous growth hormone in growth hormone-deficient children
40. Effects of low-dose recombinant human insulin-like growth factor 1 on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus
41. Influence of growth hormone on splanchnic glucose production in man
42. Metasomatotrophic diabetes and its induction: Basal insulin secretion and insulin release responses to glucose, glucagon, arginine and meals
43. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: A report of one-year clinical experience
44. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans
45. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men
46. Effects of short-term administration of growth hormone in healthy young men, women, and women taking oral contraceptives
47. Serum levels of insulin-like growth factor 1 and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men
48. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women
49. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults